Request Deal Involvement

Advent and Warburg Pincus completed the acquisition of the BioPharma Solutions business of Baxter for $4.25bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ropes & Gray

legal advisors

Ropes & Gray

Truist Securities

financial advisors

Truist Securities

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

Hengeler Mueller

legal advisors

Hengeler Mueller

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

Moelis & Co

financial advisors

Moelis & Co

Milbank

legal advisors to debt providers

Milbank

FGS Global

pr advisors

FGS Global

or

Principals

BAXTER (BIOPHARMA SOLUTIONS)

target

BAXTER (BIOPHARMA SOLUTIONS)

WARBURG PINCUS LLC

bidder

WARBURG PINCUS LLC

BAXTER INTERNATIONAL INC

vendor

BAXTER INTERNATIONAL INC

ADVENT INTERNATIONAL CORPORATION

bidder

ADVENT INTERNATIONAL CORPORATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Advent and Warburg Pincus completed the acquisition of the BioPharma Solutions business of Baxter for $4.25bn.